In the News

In the News

Shifting the treatment
paradigm for autoimmune
disease toward Navacimâ„¢-directed
immune regulation

05.17.19 | Fierce Biotech 

Genentech joins immune tolerance field with Parvus hookup

  View
05.16.19 | BioCentury 

Genentech adds to autoimmune pipeline with Parvus Deal

  View
08.03.17 | CTV News 

'Nanomedicine': Potentially revolutionary class of drugs are made-in-Canada

  View
08.02.17 | UToday 

UCalgary researcher signs deal to develop nanomedicines for treatment of Type 1 diabetes

  View
04.19.17 | Endpoints News 

Novartis ties up with the virtual biotech Parvus to try a new approach on Type 1 diabetes

  View
02.18.16 | CBC News 

Calgary researchers working on new way to treat autoimmune diseases

  View